Abstract: A container comprising a base defining a primary storage compartment; a lid having a peripheral wall that locates over a first portion of the base to close the primary storage compartment; and a cover having a peripheral lip that locates over a second portion of the base so that the base and the cover together define a secondary storage compartment, is disclosed. The primary storage compartment is closed by the lid and the cover is received on the base with the peripheral wall of the lid and the peripheral lip of the cover extending towards each other.

Abstract: A composition intended to be employed for therapeutic purposes incorporates a nicotinic compound, a sugar substitute, and a sugar alcohol syrup. Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) or nicotine polacrilex. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and as a nicotine replacement therapy.

Abstract: An active ingredient-containing product suitable for the release of an active ingredient comprising an outer water-permeable pouch chamber containing an active ingredient-containing composition is disclosed. In the product, said pouch chamber is interconnected to another pouch chamber containing the same or another composition, thereby resulting in at least two interconnected pouch chambers each comprising a composition and wherein a separation section separates one pouch chamber from another. Each pouch chamber has a length of from about 1 mm to about 40 mm and a width of no greater than about 10 mm.

Abstract: A composition intended to be employed for therapeutic purposes incorporates a nicotinic compound, a sugar substitute, and a sugar alcohol syrup. Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) or nicotine polacrilex. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and as a nicotine replacement therapy.

Abstract: A composition intended to be employed for therapeutic purposes incorporates a nicotinic compound, a sugar substitute, and a sugar alcohol syrup. Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) or nicotine polacrilex. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and as a nicotine replacement therapy.

Abstract: A composition intended to be employed for therapeutic purposes incorporates a nicotinic compound, a sugar substitute, and a sugar alcohol syrup. Representative forms of nicotine include free base (e.g., as a mixture of nicotine and microcrystalline cellulose), a nicotine salt (e.g., as nicotine bitartrate) or nicotine polacrilex. The composition is useful for treatment of central nervous system conditions, diseases, and disorders, and as a nicotine replacement therapy.

Abstract: There is provided pharmaceutical compositions in the form of homogeneous interactive mixtures, which compositions comprise a pharmacologically-effective amount of an active ingredient in the form of microparticles of a size between about 0.5 ?m and about 10 ?m, which particles are attached to the surfaces of larger carrier particles with a size range of between about 10 and about 100 ?m. The carrier particle material is preferably bio- and/or mucoadhesive in its nature.